Showing results (21-30 of 93) with videos related to
Sort By:
Pageof 10
Pediatric Nephrology (Berlin, Germany)|March 25, 2022
Clinicopathologic features of non-lupus membranous nephropathy in a pediatric populationPaul Miller, Li Lei, Vivek Charu, et al.Glomerular Diseases|February 8, 2024
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Active Kidney Involvement in the United States: 2016-2020Jianling Tao, Sai Liu, Maria Montez-Rath, et al.Journal of Human Hypertension|April 25, 2026
Unmasking primary aldosteronism after kidney transplantation: a case seriesMario Funes Hernandez, Colin Lenihan, Vivek Bhalla, et al.Clinical Kidney Journal|April 12, 2021
Masking by hypokalemia-primary aldosteronism with undetectable aldosteroneRebecca A Boyle, Jessica E Baker, Vivek Charu, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2023
The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit DiseaseHalimat Afolabi, Bing M Zhang, Michelle O'Shaughnessy, et al.Kidney International Reports|May 15, 2020
Histologic Case Definition of an Atypical Glomerular Immune-Complex Deposition Following Kidney TransplantationKuo-Kai Chin, Vivek Charu, Michelle M O'Shaughnessy, et al.Human Pathology|November 11, 2017
Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypesPoonam K Panjwani, Vivek Charu, Monique DeLisser, et al.Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver diseaseVivek Charu, Jane W Liang, Ajitha Mannalithara, et al.Hepatology (Baltimore, Md.)|April 30, 2024
Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLDVivek Charu, Jane W Liang, Ajitha Mannalithara, et al.American Journal of Epidemiology|November 20, 2025
A framework for the rigorous assessment of heterogeneous treatment effects from a single randomized controlled trialJane W Liang, Lu Tian, Manjula Kurella Tamura, et al.Pageof 10